Role of oestrogen in the development of joint symptoms?
Authors:
- 1 September 2008
- journal article
- Published by Elsevier in The Lancet Oncology
- Vol. 9 (9) , 817-818
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysisThe Lancet Oncology, 2008
- Prevalence and clinical features of arthralgia/arthritis in healthy pregnant womenRheumatology International, 2008
- Long-term anti-arthritic and anti-osteoporotic effects of raloxifene in established experimental postmenopausal polyarthritisClinical and Experimental Immunology, 2008
- Effects of postmenopausal hormone therapy on rheumatoid arthritis: The women's health initiative randomized controlled trialsArthritis Care & Research, 2008
- 17β-Estradiol utilizes the estrogen receptor to regulate CD16 expression in monocytesMolecular and Cellular Endocrinology, 2007
- Will steroidal aromatase inhibitors induce rheumatoid arthritis?Annals of the Rheumatic Diseases, 2007
- Quantitative determination of steroid hormone receptor positive cells in the synovium of patients with rheumatoid arthritis and osteoarthritis: is there a link to inflammation?Annals of the Rheumatic Diseases, 2007
- Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imagingBreast Cancer Research and Treatment, 2006
- Non‐steroidal anti‐oestrogens inhibit the differentiation of synovial macrophages into dendritic cellsRheumatology, 2001